Stocktoria

Aclarion, Inc. ACON

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2022-04-22 · LEI

Aclarion, Inc. statistics & valuation

Market cap$7.0M
P / S92.7×
P / B0.5×
Net margin-9551.9%
Return on equity-56.4%
FCF margin-9488.6%
Return on capital-54.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-8210.50% -11694.40% -6513.40% -15293.80% -9551.90% 20212022202320242025
Gross margin (%)
-14.70% -8.00% -0.40% -85.20% 9.00% 20212022202320242025
Operating margin (%)
-4897.90% -9201.20% -6466.50% -12057.20% -9312.50% 20212022202320242025
Return on equity (%)
-317.60% -720.90% -56.40% 20212022202320242025
Shares outstanding
905685 491345 825459 1370 854371 20212022202320242025
Net debt ($)
20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-262.00% -242.50% -199.70% -329.30% -52.90% 20212022202320242025
Free cash flow margin (%)
-4836.50% -11540.40% -9488.60% 20212022202320242025
Debt / equity (×)
20212022202320242025
EPS ($)
-$6.58 -$19.61 -$79782.00 -$7478.90 -$13.61 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Gross margin9.0%-85.2%-0.4%-8.0%-14.7%
Operating margin-9312.5%-12057.2%-6466.5%-9201.2%-4897.9%
Net margin-9551.9%-15293.8%-6513.4%-11694.4%-8210.5%
FCF margin-9488.6%-11540.4%-4836.5%——
Return on assets-52.9%-329.3%-199.7%-242.5%-262.0%
Return on equity-56.4%-720.9%674.6%-317.6%38.6%
Current ratio14.810.710.402.470.10

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.